CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
MeV-RII_HepG2, a persistently measles virus (MeV) infected human hepatoma cell line, displays resistance towards secondary infections with MeV virotherapeutics
DOI 10.1055/s-0033-1352728
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Berchtold, T Weiland, J Lampe, I Smirnow, S Venturelli, A Berger, J Reiser, F Stubenrauch, NP Malek, M Bitzer, UM Lauer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: The oncolytic potential of measles vaccine virus (MeV) has been shown both in vitro and in vivo. On the contrary, resistances to MeV-mediated oncolysis were demonstrated to either pre-exist or arise in the course of MeV virotherapy. To investigate mechanisms of secondary resistance we have generated a hepatoma cell line being persistently infected with MeV (MeV-RII_HepG2) which was generated by two rou…
Zitieren
Zitierempfehlung
S Berchtold, T Weiland, J Lampe, I Smirnow, S Venturelli, A Berger, J Reiser, F Stubenrauch, NP Malek, M Bitzer, UM Lauer (2013) MeV-RII_HepG2, a persistently measles virus (MeV) infected human hepatoma cell line, displays resistance towards secondary infections with MeV virotherapeutics. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0033-1352728
Mit CareLit weiterarbeiten